Revised Law Includes Designated Funding for Rare Diseases
Site Search
Showing 1 - 10 of 29 results
Press Release
|
Oct. 3, 2005
|
5 min read
Press Release
|
Feb. 14, 2006
|
3 min read
Press Release
|
Jan. 18, 2006
|
3 min read
Press Release
|
April 24, 2008
|
2 min read
Cystic Fibrosis Foundation Drug Development Model Spawns More Than 30 Promising Therapies
Press Release
|
May 19, 2010
|
3 min read
Press Release
|
Feb. 4, 2008
|
6 min read
Press Release
|
July 16, 2008
|
5 min read
Today, the Cystic Fibrosis Foundation announced a new award of up to $2 million to Eloxx Pharmaceuticals Inc. to support the global Phase 2 clinical program of ELX-02, a potential therapy to treat people with cystic fibrosis who have nonsense mutations.
Press Release
|
June 13, 2021
|
4 min read
Today, the Cystic Fibrosis Foundation announced that it has awarded up to $400,000 to Life Edit Therapeutics Inc. to explore the application of their unique gene editing technology in CF.
Press Release
|
Sept. 23, 2021
|
3 min read
Funding will support improved detection, diagnosis, prevention, and treatment of infections related to cystic fibrosis.
Press Release
|
Oct. 18, 2018
|
4 min read